ADSL and prostate cancer: Antimicrobial peptides (AMPs) from B. marimammalium also exhibited dose-dependent antiproliferative effects on PC3 prostate cancer cells, achieving 10–37% inhibition at 50–200 μg concentrations, compared to cisplatin (Figure 7).